Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shaken By Recall Of Claris' IV Products, Pfizer Puts Brakes On Vials Too; Vows To Ensure Patient Safety

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Faced with an undesirable ordeal of a nationwide recall of metronidazole, ciprofloxacin and ondansetron in the United States - the three intravenous hospital products sourced from its Indian partner Claris Lifesciences - the world's largest pharma company Pfizer has decided to stop distribution of the vial forms of the drug "out of abundance of caution.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC075286

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel